Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F. Ambinder

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Nature Medicine|September 9, 2008
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumorsDe-Xue Fu, Yvette Tanhehco, Jianmeng Chen, et al.
Journal of Virology|March 9, 2002
Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirusChuang-Jiun Chiou, Lynn J Poole, Peter S Kim, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumorsJianqing Lin, Jill Gilbert, Michelle A Rudek, et al.
Cancer Research|January 4, 2008
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceWilliam Matsui, Qiuju Wang, James P Barber, et al.
Plos Pathogens|March 20, 2026
EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc modelLeena Yoon, Lauren N MacMullen, Leonardo Josué Castro Muñoz, et al.
Haematologica|February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
AIDS (London, England)|June 22, 2022
Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosisShiyu Wang, Sergiu Pasca, Wendy S Post, et al.
Cell Death and Differentiation|February 22, 2023
A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagyLili Li, Xing-Sheng Shu, Hua Geng, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Nature Medicine|September 9, 2008
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumorsDe-Xue Fu, Yvette Tanhehco, Jianmeng Chen, et al.
Journal of Virology|March 9, 2002
Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirusChuang-Jiun Chiou, Lynn J Poole, Peter S Kim, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2009
A phase I dose-finding study of 5-azacytidine in combination with sodium phenylbutyrate in patients with refractory solid tumorsJianqing Lin, Jill Gilbert, Michelle A Rudek, et al.
Cancer Research|January 4, 2008
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceWilliam Matsui, Qiuju Wang, James P Barber, et al.
Plos Pathogens|March 20, 2026
EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc modelLeena Yoon, Lauren N MacMullen, Leonardo Josué Castro Muñoz, et al.
Haematologica|February 29, 2020
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
AIDS (London, England)|June 22, 2022
Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosisShiyu Wang, Sergiu Pasca, Wendy S Post, et al.
Cell Death and Differentiation|February 22, 2023
A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagyLili Li, Xing-Sheng Shu, Hua Geng, et al.
Pageof 22